Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Multicenter, Open-Label First-in-Human, Proof-of-Concept Study to Evaluate the Safety, Tolerability and Efficacy of OTX-TIC (travoprost) Implant in Subjects with Primary Open-Angle Glaucoma or Ocular Hypertension

Trial Profile

A Prospective, Multicenter, Open-Label First-in-Human, Proof-of-Concept Study to Evaluate the Safety, Tolerability and Efficacy of OTX-TIC (travoprost) Implant in Subjects with Primary Open-Angle Glaucoma or Ocular Hypertension

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Travoprost (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Adverse reactions; First in man; Proof of concept
  • Most Recent Events

    • 07 Aug 2019 According to an Ocular Therapeutix media release, the company is also evaluating two new formulations of OTX-TIC that will be dosed in patients in the upcoming months.
    • 10 May 2019 According to an Ocular Therapeutix media release, interim results from this study were presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meetings.
    • 24 Apr 2019 According to an Ocular Therapeutix media release, preliminary findings from this study will be highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting (April 28-May 2, in Vancouver B.C).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top